They made them "HEROES" Because They Didnt Understand

REMINDER: Robert F. Kennedy Jr. has invested in a gene-editing biotech company, CRISPR Therapeutics, while also expressing concerns about the safety of gene-editing technologies. If confirmed as head of the Department of Health and Human Services, he plans to divest from these investments to avoid conflicts of interest. Kennedy has expressed concerns about the safety of gene-editing technologies like CRISPR. He has previously highlighted potential risks, including unintended DNA disruptions. This raises questions about how he would regulate such technologies if confirmed as the head of the Department of Health and Human Services (HHS).

Plans for Divestment
If confirmed as HHS Secretary, Kennedy has stated he will divest from these biotech companies within 90 days. This is part of his commitment to avoid conflicts of interest while in office. He has also indicated he will refrain from participating in decisions that could financially impact these companies until he has fully divested. CONNECT SEE BIO OR CLICK LINK linktr.ee/EXCITATALUXLSNT

ENTERTAINMENT PURPOSE ONLY